Evidence map›Paper›PMID 42645394›Full record

ArticleCurrent oncology (Toronto, Ont.)2026

Metabolic Response to an Individualized Multimodal Treatment Strategy in Advanced Pancreatic Adenocarcinoma: A Case Report.

Mehmet Salih İyikesici, Oral Oncul, Metin Hallaç, Sena Şen, Şirin Taflan, Selin Oncul, Tomas Duraj, Thomas N Seyfried

Abstract readCase Reports
In one paragraph

Article in Current oncology (Toronto, Ont.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mehmet Salih İyikesiciNeolife Oncology Centre, 34340 Istanbul, Türkiye.ORCID 0000-0003-4677-2236
Oral OnculDepartment of Infectious Diseases and Clinical Microbiology, Division of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, 34093 Istanbul, Türkiye.
Metin HallaçNeolife Oncology Centre, 34340 Istanbul, Türkiye.
Sena ŞenDepartment of Basic Oncology, Oncology Institute, Istanbul University, 34093 Istanbul, Türkiye.ORCID 0000-0003-3967-8903
Şirin TaflanNeolife Oncology Centre, 34340 Istanbul, Türkiye.
Selin OnculMedical School, Kings College of London, London WC2R 2LS, UK.ORCID 0009-0002-4912-236X
Tomas DurajDepartment of Biology, Boston College, Boston, MA 02467, USA.ORCID 0000-0002-7778-0194
Thomas N SeyfriedDepartment of Biology, Boston College, Boston, MA 02467, USA.ORCID 0000-0003-1491-3989

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdenocarcinomaAntineoplastic Combined Chemotherapy ProtocolsPancreatic NeoplasmsCombined Modality TherapyHumansMaleMiddle Aged18F-FDG PET/CTcase reportcombined multimodal therapylow-dose/metronomic chemotherapymetabolic responsepancreatic adenocarcinoma

Identifiers

PMID42645394
PMCPMC13511654

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.